Does Allopurinol Regress Left Ventricular Hypertrophy in Patients With Treated Essential Hypertension? (The ALLAY-EH Trial)

Donnan, Peter (Investigator)
Gandy, Stephen (Investigator)
George, Jacob (Investigator)
Houston, Graeme (Investigator)
Lang, Chim (Investigator)
MacDonald, Thomas (Investigator)
Ogston, Simon (Investigator)
Struthers, Allan (Investigator)

2 Article

2 results

2020
Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function: a randomised controlled trial
Witham, M. D., Clarke, C. L., Hutcheon, A., Gingles, C., Gandy, S., Priba, L., Nicholas, R. S., Cavin, I., Sumukadas, D., Struthers, A. D. & George, J., Nov 2020, In: Age and Ageing. 49, 6, p. 1003-1010 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
2 Citations (Scopus)

51 Downloads (Pure)
2019
Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension
Gingles, C., Symon, R., Gandy, S., Struthers, A., Houston, G., MacDonald, T., Lang, C., Donnan, P. & George, J., Dec 2019, In: Journal of Hypertension. 37, 12, p. 2481-2489 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
17 Citations (Scopus)

196 Downloads (Pure)